131 related articles for article (PubMed ID: 23609360)
1. Combination of targeting gene-viro therapy with recombinant Fowl-pox viruses with HN and VP3 genes on mouse osteosarcoma.
Zhang ZY; Wang LQ; Fu CF; Li X; Cui ZL; Zhang JY; Xue SH; Sun N; Xu F
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(6):767-76. PubMed ID: 23609360
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitro.
Li X; Jin N; Mi Z; Lian H; Sun L; Li X; Zheng H
Int J Cancer; 2006 Dec; 119(12):2948-57. PubMed ID: 17036330
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of the Newcastle disease viral hemagglutinin-neuraminidase gene is expressed through an oncolytic adenovirus effect in osteosarcoma cells.
Chen S; Zhang Q; Xu D; Li Y; Fan Y; Li W; Yin X; Zhang Y; Liu J; Li X; Sun L; Jin N
Anticancer Drugs; 2018 Mar; 29(3):197-207. PubMed ID: 29438228
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor effects of an oncolytic adenovirus expressing hemagglutinin-neuraminidase of Newcastle disease virus in vitro and in vivo.
He D; Sun L; Li C; Hu N; Sheng Y; Chen Z; Li X; Chi B; Jin N
Viruses; 2014 Feb; 6(2):856-74. PubMed ID: 24553109
[TBL] [Abstract][Full Text] [Related]
6. Apoptin enhances the oncolytic properties of Newcastle disease virus.
Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma].
Wu Q; Yang SH; Ye SN; Wang RY
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):409-13. PubMed ID: 15854533
[TBL] [Abstract][Full Text] [Related]
8. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Morales-Molina A; Gambera S; Leo A; García-Castro J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma.
Liu L; Wu W; Zhu G; Liu L; Guan G; Li X; Jin N; Chi B
Int J Mol Med; 2012 Oct; 30(4):747-54. PubMed ID: 22842823
[TBL] [Abstract][Full Text] [Related]
10. [The study of recombinant plasmid of NP, HN and F gene therapy on the transplantable model of human laryngeal squamous carcinoma in nude mice].
Yu J; Wang L; Jiang W; Li Y; Wang J
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(23):1082-4. PubMed ID: 16494012
[TBL] [Abstract][Full Text] [Related]
11. Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL.
Liu X; Cao X; Wei R; Cai Y; Li H; Gui J; Zhong D; Liu XY; Huang K
Cancer Gene Ther; 2012 Jan; 19(1):49-57. PubMed ID: 21979578
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of cell-mediated immune responses against recombinant HN protein of Newcastle disease virus by recombinant chicken IL-18.
Su BS; Shen PC; Hung LH; Huang JP; Yin HS; Lee LH
Vet Immunol Immunopathol; 2011 Jun; 141(3-4):283-92. PubMed ID: 21507491
[TBL] [Abstract][Full Text] [Related]
13. The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma.
Martínez-Vélez N; Xipell E; Vera B; Acanda de la Rocha A; Zalacain M; Marrodán L; Gonzalez-Huarriz M; Toledo G; Cascallo M; Alemany R; Patiño A; Alonso MM
Clin Cancer Res; 2016 May; 22(9):2217-25. PubMed ID: 26603261
[TBL] [Abstract][Full Text] [Related]
14. Molecularly modified VP3 (30-121) induces apoptosis in human bladder cancer (EJ) cells but not in normal (3T3) cells.
Yang J; Wang J; Zuo Y; Zhan H
Cell Biol Int; 2012 Nov; 36(11):1037-42. PubMed ID: 23075302
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI-p53 complexes.
Densmore CL; Kleinerman ES; Gautam A; Jia SF; Xu B; Worth LL; Waldrep JC; Fung YK; T'Ang A; Knight V
Cancer Gene Ther; 2001 Sep; 8(9):619-27. PubMed ID: 11593330
[TBL] [Abstract][Full Text] [Related]
16. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of VEGF-siRNA mediated by adenovirus on osteosarcoma-bearing nude mice.
Gao YS; Mei J; Tong TL; Hu M; Xue HM; Cai XS
Cancer Biother Radiopharm; 2009 Apr; 24(2):243-7. PubMed ID: 19409047
[TBL] [Abstract][Full Text] [Related]
18. Antisense suppression of the chloride intracellular channel family induces apoptosis, enhances tumor necrosis factor {alpha}-induced apoptosis, and inhibits tumor growth.
Suh KS; Mutoh M; Gerdes M; Crutchley JM; Mutoh T; Edwards LE; Dumont RA; Sodha P; Cheng C; Glick A; Yuspa SH
Cancer Res; 2005 Jan; 65(2):562-71. PubMed ID: 15695400
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma and interferon. Studies of human xenografts in the nude mouse.
Brosjö O
Acta Orthop Scand Suppl; 1989; 229():1-36. PubMed ID: 2494840
[TBL] [Abstract][Full Text] [Related]
20. Triazine-modified dendrimer for efficient TRAIL gene therapy in osteosarcoma.
Wang Y; Li L; Shao N; Hu Z; Chen H; Xu L; Wang C; Cheng Y; Xiao J
Acta Biomater; 2015 Apr; 17():115-24. PubMed ID: 25595474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
